Stem cells as cancer therapyDecember 26, 2006Stem cells and metastatic cancer: fatal attraction? It is widely hoped that neural stem cells will eventually be useful for replacing nerves damaged by degenerative diseases like Alzheimer disease and multiple sclerosis. But there may also be another use for such stem cells-delivering anti-cancer drugs to cancer cells. A Perspective article in PLoS Medic ine, by Professor Riccardo Fodde (Erasmus Medical Center, The Netherlands), discusses a new study in mice, published in the launch issue of PLoS ONE - http://www.plosone.org - that showed that neural stem cells could be used to help deliver anti-cancer drugs to metastatic cancer cells.
One of the characteristics of neural stem cells is their tendency to move towards diseased areas (scientists call this phenomenon "pathotropism"). This characteristic, says Professor Fodde, "makes them particularly attractive candidates not only to replace damaged tissue in degenerative pathologies, but also to deliver therapeutic molecules in patients with disseminated metastatic cancer." In the study published in PLoS ONE, Karen Aboody and colleagues report on the eradication of disseminated metastases in a mouse model of a cancer called neuroblastoma. The researchers took advantage of the tumor-tropic (selective migration towards cance r cells) properties of neural stem cells engineered to express an enzyme that activates an anti-cancer drug. It is much too early to know whether this study in mice will lead to any kind of valuable treatment for humans with cancer. Clinical trials in humans are needed before doctors can know whether stem cells have a role in cancer therapy. Professor Fodde also says that there will be a number of concerns about the safety of such human trials, which he discusses in his Perspective. Public Library of Science | |||||||||||||||||||||
|
Related Cancer Therapy Current Events and Cancer Therapy News Articles Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center. Researchers identify mechanism used by gene to promote metastasis in human cancer cells Virginia Commonwealth University Institute of Molecular Medicine and VCU Massey Cancer Center researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers. New way to control protein activity could lead to cancer therapies Investigators at the Stanford University School of Medicine have found a way to quickly and reversibly fine-tune the activity of individual proteins in cells and living mammals, providing a powerful new laboratory tool for identifying - more precisely than ever before - the functions of different proteins. New research to help dogs with cancer may benefit people A new study jointly conducted by Oregon State University College of Veterinary Medicine and the Oregon Health & Science University Cancer Institute may one day help not only our canine friends with cancer, but also people with the human form of the disease. Joining forces against cancer In cancer therapy, the best results are often achieved by combining treatments such as chemotherapy, radiotherapy and surgery. Atomic structure of the mammalian 'fatty acid factory' determined Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. True properties of carbon nanotubes measured For more than 15 years, carbon nanotubes (CNTs) have been the flagship material of nanotechnology. Researchers have conceived applications for nanotubes ranging from microelectronic devices to cancer therapy. Their atomic structure should, in theory, give them mechanical and electrical properties far superior to most common materials. By amplifying cell death signals, scientists make precancerous cells self-destruct When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction. Vitamin C injections slow tumor growth in mice High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the Proceedings of the National Academy of Sciences. CSHL scientists correlate enzyme expression levels with chemotherapy drug response Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs seem to be working well to reduce tumors or hold them in check? Although largely a mystery to scientists, the result when this occurs is all too familiar: patients relapse and in many cases die when their cancers become resistant. More Cancer Therapy Current Events and Cancer Therapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||